JCRB0177.1 KP-1NL

Cell information

Important Notice(s)

JCRB0177.0 KP-1N, JCRB0177.1 KP-1NL細胞の由来の問題について

Problem of identity in JCRB0177.0 KP-1N and JCRB0177.1 KP-1NL.

Cell type:general cells (Charges for cells)

JCRB No.   JCRB0177.1 Cell Name   KP-1NL
profile   Stop providing for the issue of quality control. (Please contact us for more information) Cells established from the resulting tumor nodules in the liver of mouse, into the spleen where KP-1N cells had been injected. Alias   
animal   human strain   
genus   Homo species   sapiens
sex   M age   69
identity   available tissue   pancreas
case history   pancreatic cancer metastasis   Yes
metastorgn   liver genetics   
lifespan   infinite crisispdl   
morphology   epithelial-like charact   Cells were established from the resulting tumor nodules in the liver of mouse, into the spleen where KP-1N cells had been injected.
classify   tumor originator   Kono,A. et.al.
register   Iguchi,H. regulation   
comment   Cells were identified to be unique on 10/17/2001 by STR-PCR. dyear   2001
medium   RPMI1640 medium with 10% fetal bovine serum. pasmethod   Cells are harvested after treatment with 0.02% EDTA and 0.1% trypsin. Subculture when cells reach to subconfluent.
pascellno   1-2 x 10^5 cells/T25 frask race   Japanese
co2conc   5 % tohroku   registered
preporgn   pancreas vrsummary   teste
vrsdetect   GAPDH(+), CMV(-), EBV(-), HHV6(-), HHV7(-), BKV(-), JCV(-), ADV(-), HBV(-), parvoB19(-), HTLV1(-), HTLV2(-), HIV1(-), HIV2(-), HPV18(-)[-/negative, +/positive, nt/not tested, GAPDH = positive control] tissueform   


References
Pubmed id:9735394 Alteration of the CDKN2A gene in pancreatic cancers: Is it a late event in the progression of pancreatic cancer?
Sugimoto Y,Morita R,Hikiji K,Imura G,Ogata Y,Yasuda D,Kono A,Iguchi H
Int J Oncol. 1998 Oct;13(4):669-76
Pubmed id:21607521 Alterations of the p53 tumor-suppressor gene and ki-ras oncogene in human pancreatic cancer-derived cell-lines with different metastatic potential.
Iguchi H,Morita R,Yasuda D,Takayanagi R,Ikeda Y,Takada Y,Shimazoe T,Nawata H,Kono A
Oncol Rep. 1994 Nov;1(6):1223-7
Pubmed id:2172194 Establishment and characterization of human pancreatic cancer cell lines in tissue culture and in nude mice.
Ikeda Y,Ezaki M,Hayashi I,Yasuda D,Nakayama K,Kono A
Jpn J Cancer Res. 1990 Oct;81(10):987-93
Images



LOT Information

Cell No.   JCRB0177.1 Cell Name   
LOT No.   05282004 LOTSPEC   distribution
MEDIUM   RPMI1640 medium with 10% fetal bovine serum (FBS lot; GIBCO 3762782S) GROWTEMP   37 C
PASCELLNO   1 x 10^5 cells/ml PASMETHOD   0.25% trypsin and 0.02% EDTA
GROWTHRATE   30 - 40 hrs FREEZCONC   2.4 x 10^6
VIABLFREEZ   94 ANTIBIOTIC   free
PASSAGE   P11* PDL   
MYCO   - BACT   -
PROTOZOA    ISOZYME   Confirmed as human by NP, G6PD (type B), MD, AST.
CHRMODE    CHRDISTRB   
SURFACEAG    DNA Profile (STR)   
ANCHORDEPD   Yes EXOGENE   
FMEDIUM   10% DMSO, 20% FBS - RPMI1640 CO2   5%
SCFREQ    RFLP   
FROMLOT   


Cell No.   JCRB0177.1 Cell Name   KP-1NL
LOT No.   10202001 LOTSPEC   distribution
MEDIUM   RPMI1640 medium with 10 % fetal calf serum (Intergen RB52405). GROWTEMP   37 C
PASCELLNO   2.0 x 10^4 cells/sq.cm. PASMETHOD   Cells were harvested after treatment with 0.1% trypsin.
GROWTHRATE   NT FREEZCONC   1.5 x 10^6
VIABLFREEZ   98.7 ANTIBIOTIC   free
PASSAGE   P7* PDL   NT
MYCO   NT BACT   NT
PROTOZOA   NT ISOZYME   G6PD(typeB), NP, LDH examined. Human not HeLa.
CHRMODE   NT CHRDISTRB   NT
SURFACEAG   NT DNA Profile (STR)   
ANCHORDEPD   Yes EXOGENE   NT
FMEDIUM   Culture medium containing 5% DMSO. CO2   5 %
SCFREQ    RFLP   NT
FROMLOT   6122001


Images
CLOSE